The Internet of Things (IoT) is undergoing significant advancements, driven by the emergence of Backscatter Communication (BC) and Artificial Intelligence (AI). BC is an energy-saving and cost-effective communication method where passive Backscatter Devices (BD) communicate by modulating ambient Radio-Frequency (RF) carriers. AI has the potential to transform our way of communicating and interacting and represents a powerful tool for enabling the next generation of IoT devices and networks. By integrating AI with BC, we can create new opportunities for energy-efficient and low-cost communication and open the door to a range of innovative applications that were previously not possible. This paper brings these two technologies together to investigate the current state of AI-powered BC. We begin with an introduction to BC and an overview of the AI algorithms employed in BC. Then, we delve into the recent advances in AI-based BC, covering key areas such as backscatter signal detection, channel estimation, and jammer control to ensure security, mitigate interference, and improve throughput and latency. We also explore the exciting frontiers of AI in BC using B5G/6G technologies, including backscatter-assisted relay and cognitive communication networks, backscatter-assisted MEC networks, and BC with Reconfigurable Intelligent Surfaces (RIS), UAV, and vehicular networks. Finally, in the discussion section, we summarize the solutions, provide lessons learned and challenges, and present new research opportunities in AI-powered BC. This survey provides a comprehensive overview of the potential of AI-powered BC and its insightful impact on the future of IoT.

Cyanobacteria (blue-green microalgae) are ubiquitous, Gram-negative photoautotrophic prokaryotes. They are considered as one of the most efficient sources of bioactive secondary metabolites. More than 50% of cyanobacteria are cultivated on commercial platforms to extract bioactive compounds, which have bene shown to possess anticancer activity. The chemically diverse natural compounds or their analogues induce cytotoxicity and potentially kill a variety of cancer cells via the induction of apoptosis, or altering the activation of cell signaling, involving especially the protein kinase-C family members, cell cycle arrest, mitochondrial dysfunctions and oxidative damage. These therapeutic properties enable their use in the pharma and healthcare sectors for the betterment of future generations. This review provides a baseline overview of the anti-cancerous cyanobacterial bioactive compounds, along with recently introduced nanomaterials that could be used for the development of new anticancer drugs to build a healthy future for mankind.